Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.

BMC Cancer
Karina UeharaTakao Kinjo

Abstract

Low-risk human papillomavirus (HPV), such as types 6 and 11, is considered non-oncogenic, but these types have been detected in oral cancer tissue samples, suggesting their possible involvement in oral carcinogenesis. Because double infection of high-risk HPV and Epstein-Barr virus (EBV) is known to be involved in oral carcinogenesis, we hypothesized that low-risk HPV and EBV co-infection can transform the oral cells. To verify our hypothesis, we evaluated the transformation activity of cell lines expressing both low-risk HPV E6/E7 and EBV LMP-1. We transduced HPV6, 11 and 16 E6/E7 genes and EBV LMP-1 gene into primary mouse embryonic fibroblasts. The cell lines were examined for indices of transformation activity such as proliferation, induction of DNA damage, resistance to apoptosis, anchorage-independent growth, and tumor formation in nude mice. To evaluate the signaling pathways involved in transformation, NF-κB and p53 activities were analyzed. We also assessed adhesion signaling molecules associated with anchorage-independent growth such as MMP-2, paxillin and Cat-1. Co-expression of low-risk HPV6 E6 and EBV LMP-1 showed increased cell proliferation, elevated NF-κB activity and reduced p53 induction. Moreover, co-expressi...Continue Reading

References

Nov 11, 1992·International Journal of Cancer. Journal International Du Cancer·R FåhraeusB Obrink
Apr 1, 1991·Clinical Otolaryngology and Allied Sciences·H Lindeberg, O Elbrønd
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·X Tong, P M Howley
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·W KulwichitN Raab-Traub
Mar 16, 2000·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·K TsuhakoT Abo
Jan 9, 2001·Nature Cell Biology·C E Turner
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Aug 12, 2003·Oncogene·Lawrence S Young, Paul G Murray
Mar 1, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Aimee R KreimerSilvia Franceschi
Apr 27, 2007·Journal of Virology·Lindsey M Hutt-Fletcher
Oct 5, 2007·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·D C W LeeA S Y Lau
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Dec 5, 2012·Vaccine·John DoorbarMargaret A Stanley
May 15, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Li-Ang LeeTzu-Chen Yen
Jul 22, 2014·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Ru JiangCherie-Ann O Nathan

❮ Previous
Next ❯

Software Mentioned

ImageJ
Image J

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis